These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6453828)

  • 41. Cell surface phenotype of a cloned line of human natural killer cells.
    Kornbluth J; Flomenberg N; Dupont B
    J Immunol; 1982 Dec; 129(6):2831-7. PubMed ID: 6982944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of cytotoxic T-cell clonal expansion by cyclophosphamide and the recovery of cytotoxic T-lymphocyte precursors by supernatants from mixed-lymphocyte cultures.
    Merluzzi VJ; Walker MM; Faanes RB
    Cancer Res; 1981 Mar; 41(3):850-3. PubMed ID: 6450638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of HSV-1-induced lymphokine production in human cells by a direct indicator cell addition assay.
    Clouse KA; Bach FH; Orosz CG
    J Immunol; 1984 Jun; 132(6):2961-7. PubMed ID: 6327812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of T cell growth factor production: arrest of TCGF production after 18 hours in normal lectin-stimulated mouse spleen cell cultures.
    Gullberg M; Ivars F; Coutinho A; Larsson EL
    J Immunol; 1981 Aug; 127(2):407-11. PubMed ID: 6454723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on induction and effector functions of concanavalin A-induced suppressor cells that limit TCGF production.
    Gullberg M; Larsson EL
    J Immunol; 1982 Feb; 128(2):746-50. PubMed ID: 6459384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.
    Besser MJ; Schallmach E; Oved K; Treves AJ; Markel G; Reiter Y; Schachter J
    Cytotherapy; 2009; 11(2):206-17. PubMed ID: 19148842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression.
    López-Botet M; Silva A; Rodríguez J; de Landazuri MO
    J Immunol; 1982 Sep; 129(3):1109-15. PubMed ID: 6213707
    [No Abstract]   [Full Text] [Related]  

  • 48. Human T-cell growth factor: parameters for production.
    Ruscetti FW; Mier JW; Gallo RC
    J Supramol Struct; 1980; 13(2):229-41. PubMed ID: 6972470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation.
    Risdon G; Gaddy J; Stehman FB; Broxmeyer HE
    Cell Immunol; 1994 Mar; 154(1):14-24. PubMed ID: 8118883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments.
    Ruiz M; Roodman ST; Bouhasin JD; Knutsen AP
    Stem Cells; 1996 Jan; 14(1):132-45. PubMed ID: 8820959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of IL 2 responsiveness in a murine IL 3-dependent cell line.
    Le Gros GS; Gillis S; Watson JD
    J Immunol; 1985 Dec; 135(6):4009-14. PubMed ID: 3934272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.
    Bonnard GD; Yasaka K; Jacobson D
    J Immunol; 1979 Dec; 123(6):2704-8. PubMed ID: 315430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promotion of hematopoietic stem cell differentiation in vitro by a soluble mediator, allogeneic effect factor.
    Altman A; Gilmartin TD; Katz DH
    J Supramol Struct; 1980; 14(3):383-95. PubMed ID: 6971373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.
    Gillis S; Smith KA; Watson J
    J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bovine T lymphocytes. I. Generation and maintenance of an interleukin-2-dependent, cytotoxic T-lymphocyte cell line.
    Picha KS; Baker PE
    Immunology; 1986 Jan; 57(1):131-6. PubMed ID: 2417937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunologic functions of isolated human lymphocyte subpopulations. III. Specific allogeneic lympholysis mediated by human T cells alone.
    Sondel PM; Chess L; MacDermott RP; Schlossman SF
    J Immunol; 1975 Mar; 114(3):982-7. PubMed ID: 122993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity.
    Zhao W; Xing P; Wei X; Wang T; Yang D; Li M
    Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.
    Cignetti A; Guarini A; Gillio Tos A; Reato G; Foa R
    Cancer Gene Ther; 2000 Feb; 7(2):167-76. PubMed ID: 10770624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells.
    Keever CA; Abu-Hajir M; Graf W; McFadden P; Prichard P; O'Brien J; Flomenberg N
    Bone Marrow Transplant; 1995 Mar; 15(3):407-19. PubMed ID: 7599566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.